Internal Medicine, Pulmonary Disease · Glendale, AZ
NPI
1710115423
Since 2009
Specialty
Internal Medicine, Pulmonary Disease
Code 207RP1001X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
5750 W. Thunderbird Rd., #g780
Glendale, AZ, 85306
Phone (602) 314-4220
Groups this clinician bills Medicare through
Medicare paid, 2024
$285K
3,733 services
Medicare patients, 2024
677
Average age 75
Drug cost, 2024
$13.6M
4,833 prescriptions
Company payments, 2025
$14K
From 17 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Adam R Bosak was code 99215 (office e&m - established), 563 times for 322 patients. In total Adam R Bosak billed 3,733 services in 38 codes, and Medicare paid $285K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-03-28.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Office | 563 | 322 | $133.81 | $75K |
| 99233 Hospital E&M - Subsequent | Facility | 528 | 160 | $92.28 | $49K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 472 | 310 | $13.13 | $6,199 |
| 99497 Care Management/Coordination | Office | 401 | 398 | $61.87 | $25K |
| 99232 Hospital E&M - Subsequent | Facility | 285 | 119 | $61.20 | $17K |
| 99223 Hospital E&M - Initial | Facility | 144 | 126 | $132.54 | $19K |
| 99214 Office E&M - Established | Office | 125 | 105 | $100.54 | $13K |
| 99291 Critical Care E&M | Facility | 122 | 50 | $158.72 | $19K |
| 94726 Pulmonary Function Testing | Office | 119 | 118 | $40.91 | $4,869 |
| 94729 Pulmonary Function Testing | Office | 119 | 118 | $41.95 | $4,992 |
| 94060 Pulmonary Function Testing | Office | 116 | 115 | $28.77 | $3,338 |
| 99205 Office E&M - New | Office | 94 | 94 | $162.02 | $15K |
| 99307 SNF E&M | Facility | 84 | 16 | $32.22 | $2,707 |
| 94010 Pulmonary Function Testing | Office | 81 | 81 | $21.15 | $1,713 |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 68 | 17 | $0.78 | $53.29 |
By year: 2022 $203K for 2,432 services; 2023 $235K for 3,159 services; 2024 $285K for 3,733 services.
Medicare prescription drug claims, 2024
In 2024, the drug Adam R Bosak prescribed most often to Medicare patients was Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter), with 803 prescriptions and refills. In total Adam R Bosak wrote 4,833 Medicare prescriptions that cost $13.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 803 | 1,181 | 181 | $744K |
| Albuterol Sulfate Hfa Albuterol Sulfate | 309 | 403 | 121 | $7,948 |
| Prednisone Generic | 298 | 383 | 142 | $952 |
| Montelukast Sodium Generic | 279 | 686 | 84 | $3,210 |
| Adempas Riociguat | 234 | 234 | 28 | $3.2M |
| Breztri Aerosphere Budesonide/Glycopyr/Formoterol | 217 | 305 | 61 | $190K |
| Opsumit Macitentan | 199 | 199 | 27 | $2.5M |
| Levocetirizine Dihydrochloride Generic | 199 | 383 | 54 | $2,563 |
| Pantoprazole Sodium Generic | 176 | 370 | 57 | $2,280 |
| Ipratropium Bromide Generic | 128 | 216 | 58 | $3,344 |
| Tyvaso Dpi Treprostinil | 123 | 123 | 19 | $2.9M |
| Fluticasone Propionate Generic | 111 | 243 | 56 | $1,304 |
| Uptravi Selexipag | 110 | 110 | 13 | $2.3M |
| Furosemide Generic | 94 | 174 | 25 | $299 |
| Trazodone Hcl Generic | 78 | 126 | 19 | $1,148 |
Brand drugs: 2,397 claims; generic drugs: 2,436 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Adam R Bosak $14K ($14K in general payments such as food, travel and fees) from 17 companies. The largest payer was Actelion Pharmaceuticals US, Inc. with $9,127.
| Company | Payments | Amount |
|---|---|---|
| Actelion Pharmaceuticals US, Inc. JNJ | 20 | $9,127 |
| United Therapeutics Corporation UTHR | 12 | $4,196 |
| Genzyme Corporation SNY | 9 | $161 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $155 |
| Merck Sharp & Dohme LLC MRK | 6 | $138 |
| Inspire Medical Systems, Inc. INSP | 1 | $137 |
| Regeneron Healthcare Solutions, Inc. REGN | 3 | $88.58 |
| GlaxoSmithKline, LLC. GSK | 4 | $85.33 |
| Grifols USA, LLC | 2 | $69.53 |
| Amgen Inc. AMGN | 2 | $39.23 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.